http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 02 Sep 2026 06:48:12 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Pelican+AI+names+Nino+Di+Teodoro+as+new+CEO/27015409.html <p>Pelican AI (CSE: PEL), a Toronto-based provider of artificial intelligence-powered payments and financial crime compliance solutions, has appointed Nino Di Teodoro as Chief Executive Officer, according to a company statement.</p><p>Di Teodoro brings more than two decades of experience in financial services, payments, digital banking and financial crime compliance. Most recently, he served as Vice President at Symcor, where he led business process optimization and fraud and financial crimes product lines. He previously held senior roles at Central 1 Credit Union and has held positions at Meridian Credit Union, Thales, TD Bank Group, Citi Cards Canada and CIBC. He holds a http://www.streetinsider.com/Corporate+News/Pelican+AI+names+Nino+Di+Teodoro+as+new+CEO/27015409.html Wed, 02 Sep 2026 06:48:12 -0400 PEL http://www.streetinsider.com/Press+Releases/Pelican+AI+Appoints+Nino+Di+Teodoro+as+Chief+Executive+Officer+to+Lead+Next+Phase+of+Commercial+Growth/27015400.html <p>Seasoned financial services and payments executive brings more than two decades of leadership experience as Pelican focuses on expanding global banking relationships, entering new markets and accelerating product commercialization</p><p>Toronto, Ontario--(Newsfile Corp. - September 2, 2026) - Pelican AI&#160;(CSE: PEL)&#160;("<b>Pelican</b>" or the "<b>Company</b>"), a provider of artificial intelligence-powered payments, financial crime compliance and trade finance solutions, is pleased to announce the appointment of Nino Di Teodoro as Chief Executive Officer.</p><p>Mr. Di Teodoro brings more than two decades of senior leadership experience across financial services, payments, digital banking and financial crime compliance. His appointment comes as Pelican enters its next stage of http://www.streetinsider.com/Press+Releases/Pelican+AI+Appoints+Nino+Di+Teodoro+as+Chief+Executive+Officer+to+Lead+Next+Phase+of+Commercial+Growth/27015400.html Wed, 02 Sep 2026 06:45:00 -0400 PEL http://www.streetinsider.com/Newsfile/Pelican+AI+Appoints+Nino+Di+Teodoro+as+Chief+Executive+Officer+to+Lead+Next+Phase+of+Commercial+Growth/27015400.html <p>Seasoned financial services and payments executive brings more than two decades of leadership experience as Pelican focuses on expanding global banking relationships, entering new markets and accelerating product commercialization</p><p>Toronto, Ontario--(Newsfile Corp. - September 2, 2026) - Pelican AI&#160;(CSE: PEL)&#160;("<b>Pelican</b>" or the "<b>Company</b>"), a provider of artificial intelligence-powered payments, financial crime compliance and trade finance solutions, is pleased to announce the appointment of Nino Di Teodoro as Chief Executive Officer.</p><p>Mr. Di Teodoro brings more than two decades of senior leadership experience across financial services, payments, digital banking and financial crime compliance. His appointment comes as Pelican enters its next stage of http://www.streetinsider.com/Newsfile/Pelican+AI+Appoints+Nino+Di+Teodoro+as+Chief+Executive+Officer+to+Lead+Next+Phase+of+Commercial+Growth/27015400.html Wed, 02 Sep 2026 06:45:00 -0400 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html si-local-file:///var/storage/newsbody/2019/0312/15246119.html http://www.streetinsider.com/Press+Releases/Piramal+Announces+the+Launch+of+Cinacalcet+by+its+Partner%2C+Slate+Run+Pharmaceuticals%2C+in+the+U.S./15246119.html Tue, 12 Mar 2019 08:32:00 -0400 500302 500302 A.02926272 A.05450014 A.07598536 A.24844062 A.29047413 PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html si-local-file:///var/storage/newsbody/2018/1120/14849287.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Unveils+its+New+cGMP+Kilo+Lab+Suite+for+Active+Pharmaceutical+Ingredient+%28API%29+at+Ennore%2C+Chennai/14849287.html Tue, 20 Nov 2018 07:27:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html si-local-file:///var/storage/newsbody/2018/1005/14678837.html http://www.streetinsider.com/Press+Releases/Piramal+Pharma+Solutions+Announces+the+Launch+of+Xcelerate+Integrated+Solutions%E2%84%A2/14678837.html Fri, 05 Oct 2018 08:16:00 -0400 500302 A.02926272 A.05450014 A.24844062 A.29047413 PEL PEL